Search research articles
Contact Us
Filters
Showing results (31-40 of 318) with videos related to
Page
of 32
Sort By:
Clinics in Liver Disease
|
October 13, 2009
NASH and HCC
John M Page, Stephen A Harrison
Hepatology (Baltimore, Md.)
|
June 26, 2012
Hepatic progenitor cells: Another piece in the nonalcoholic fatty liver disease puzzle
Dawn M Torres, Stephen A Harrison
The Medical Clinics of North America
|
January 20, 2005
Relation of hemochromatosis with hepatocellular carcinoma: epidemiology, natural history, pathophysiology, screening, treatment, and prevention
Stephen A Harrison, Bruce R Bacon
Current Treatment Options in Gastroenterology
|
January 29, 2008
Current treatments in nonalcoholic steatohepatitis
Dawn M Torres, Stephen A Harrison
Hepatology (Baltimore, Md.)
|
September 24, 2013
Small steps toward a better treatment for chronic hepatitis C infection: mericitabine, pegylated interferon, and ribavirin in the PROPEL and JUMP-C trials
Dawn M Torres, Stephen A Harrison
Hepatology (Baltimore, Md.)
|
November 30, 2006
H. pylori and platelet counts
Hays L Arnold, Stephen A Harrison
Hepatology (Baltimore, Md.)
|
June 25, 2016
Noninvasive imaging methods to determine severity of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
William N Hannah, Stephen A Harrison
Seminars in Liver Disease
|
March 16, 2012
Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil
Dawn M Torres, Stephen A Harrison
Southern Medical Journal
|
November 22, 2005
Extrahepatic manifestations of hepatitis C
Nicole A Palekar, Stephen A Harrison
Hepatology (Baltimore, Md.)
|
February 19, 2016
Nonalcoholic fatty liver disease and elastography: Incremental advances but work still to be done
William N Hannah, Stephen A Harrison
Page
of 32
Search research articles
Search
Showing results (31-40 of 318) with videos related to
Sort By:
Page
of 32
Clinics in Liver Disease
|
October 13, 2009
NASH and HCC
John M Page, Stephen A Harrison
Hepatology (Baltimore, Md.)
|
June 26, 2012
Hepatic progenitor cells: Another piece in the nonalcoholic fatty liver disease puzzle
Dawn M Torres, Stephen A Harrison
The Medical Clinics of North America
|
January 20, 2005
Relation of hemochromatosis with hepatocellular carcinoma: epidemiology, natural history, pathophysiology, screening, treatment, and prevention
Stephen A Harrison, Bruce R Bacon
Current Treatment Options in Gastroenterology
|
January 29, 2008
Current treatments in nonalcoholic steatohepatitis
Dawn M Torres, Stephen A Harrison
Hepatology (Baltimore, Md.)
|
September 24, 2013
Small steps toward a better treatment for chronic hepatitis C infection: mericitabine, pegylated interferon, and ribavirin in the PROPEL and JUMP-C trials
Dawn M Torres, Stephen A Harrison
Hepatology (Baltimore, Md.)
|
November 30, 2006
H. pylori and platelet counts
Hays L Arnold, Stephen A Harrison
Hepatology (Baltimore, Md.)
|
June 25, 2016
Noninvasive imaging methods to determine severity of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
William N Hannah, Stephen A Harrison
Seminars in Liver Disease
|
March 16, 2012
Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil
Dawn M Torres, Stephen A Harrison
Southern Medical Journal
|
November 22, 2005
Extrahepatic manifestations of hepatitis C
Nicole A Palekar, Stephen A Harrison
Hepatology (Baltimore, Md.)
|
February 19, 2016
Nonalcoholic fatty liver disease and elastography: Incremental advances but work still to be done
William N Hannah, Stephen A Harrison
Page
of 32